KATHERINE ALLEYNE: Open Payments
NPI 1558610576 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$187 in 4 payments from 4 companies in 2025. Trend: 2023 $123 · 2024 $19 · 2025 $187
Food & beverage: $187
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 1 | $122 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Valinor Pharma, LLC | 1 | $15 |
Products named: UPTRAVI, INGREZZA, HYQVIA, MOVANTIK.
Industry payments across LA — which companies pay providers there.
